NasdaqGS:ACHCHealthcare
Assessing Acadia Healthcare Company (ACHC) Valuation After Analyst Upgrades And Higher 2026 Guidance
Acadia Healthcare Company (ACHC) is back in focus after a strong first quarter, with Raymond James upgrading the stock and the company modestly lifting its 2026 earnings and EBITDA guidance.
See our latest analysis for Acadia Healthcare Company.
Despite a 2.9% decline in the 1 day share price return to US$24.48, Acadia’s strong first quarter update and higher 2026 guidance sit alongside a 71.31% year to date share price return and a weaker 3 year total shareholder return. This suggests recent...